BFC Planning’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
Other funds holding RCKT
BFC Planning's RCKT Position: Q3 2026 in Review
BFC Planning held its Rocket Pharmaceuticals (RCKT) position steady in Q3 2026 at 3,500 shares worth $9.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2435.
BFC Planning first reported a position in RCKT in Q3 2024 and has held it in 9 quarters since. The position peaked at $65.7K in Q3 2024. 119 funds tracked by Wall St. Rank hold RCKT as of Q3 2026.
- BFC Planning held 3,500 shares of Rocket Pharmaceuticals worth $9.2K as of Q3 2026.
- BFC Planning left its Rocket Pharmaceuticals share count unchanged in Q3 2026.
- Rocket Pharmaceuticals made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2435 holding.
- BFC Planning first reported a position in Rocket Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
- BFC Planning's Rocket Pharmaceuticals position peaked at $65.7K in Q3 2024.
- 119 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.